drugset / Trial / NCT01697631
Glycemic Control of Biphasic Insulin Aspart 30 in Type 2 Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
This this trial is conducted in Europe. The aim of this trial is to compare glycaemic control of biphasic insulin aspart 30 (BIAsp 30) alone or combined with insulin aspart(IAsp) in patients previously treated with conventional Biphasic Human Insulin 30/70.
Timeline
- Start
- 2002-07-22
- Primary completion
- 2003-04-24
- Completion
- 2003-04-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | insulin aspart | Protein / enzyme biologic | — | Subcutaneous |
| Background | biphasic insulin aspart 30 | Protein / enzyme biologic | — | Subcutaneous |